These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 31897178)
1. MicroRNA-1296 expression is associated with prognosis and inhibits cell proliferation and invasion by Wnt signaling in non-small cell lung cancer. Deng H; Xie C; Ye Y; Du Z Oncol Lett; 2020 Jan; 19(1):623-630. PubMed ID: 31897178 [TBL] [Abstract][Full Text] [Related]
2. Downregulation of N-Acetylglucosaminyltransferase GCNT3 by miR-302b-3p Decreases Non-Small Cell Lung Cancer (NSCLC) Cell Proliferation, Migration and Invasion. Li Q; Ran P; Zhang X; Guo X; Yuan Y; Dong T; Zhu B; Zheng S; Xiao C Cell Physiol Biochem; 2018; 50(3):987-1004. PubMed ID: 30355927 [TBL] [Abstract][Full Text] [Related]
3. MicroRNA-1298 is downregulated in non-small cell lung cancer and suppresses tumor progression in tumor cells. Du Z; Wu J; Wang J; Liang Y; Zhang S; Shang Z; Zuo W Diagn Pathol; 2019 Dec; 14(1):132. PubMed ID: 31801557 [TBL] [Abstract][Full Text] [Related]
4. Clinical Significance and Tumor-Suppressive Function of miR-516b in Nonsmall Cell Lung Cancer. Zhu J; Zhang Y; Yang X; Jin L Cancer Biother Radiopharm; 2017 May; 32(4):115-123. PubMed ID: 28514208 [TBL] [Abstract][Full Text] [Related]
5. miR-1225-5p inhibits non-small cell lung cancer cell proliferation, migration and invasion, and may be a prognostic biomarker. Li B; Zhang F; Li H Exp Ther Med; 2020 Dec; 20(6):172. PubMed ID: 33101465 [TBL] [Abstract][Full Text] [Related]
6. miR-582-5p is a potential prognostic marker in human non-small cell lung cancer and functions as a tumor suppressor by targeting MAP3K2. Wang LL; Zhang M Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):7760-7767. PubMed ID: 30536321 [TBL] [Abstract][Full Text] [Related]
7. miR-4317 suppresses non-small cell lung cancer (NSCLC) by targeting fibroblast growth factor 9 (FGF9) and cyclin D2 (CCND2). He X; Chen SY; Yang Z; Zhang J; Wang W; Liu MY; Niu Y; Wei XM; Li HM; Hu WN; Sun GG J Exp Clin Cancer Res; 2018 Sep; 37(1):230. PubMed ID: 30227870 [TBL] [Abstract][Full Text] [Related]
8. Prognostic value of miR-1181 in non-small cell lung cancer and its regulatory effect on tumor progression. Liu F; Ma G; Wang B; Wang X; Huang C Exp Ther Med; 2021 Nov; 22(5):1284. PubMed ID: 34630639 [TBL] [Abstract][Full Text] [Related]
9. Down-regulation of microRNA-126 and microRNA-133b acts as novel predictor biomarkers in progression and metastasis of non small cell lung cancer. Chen SW; Wang TB; Tian YH; Zheng YG Int J Clin Exp Pathol; 2015; 8(11):14983-8. PubMed ID: 26823832 [TBL] [Abstract][Full Text] [Related]
10. Down-regulated MicroRNA 148b expression as predictive biomarker and its prognostic significance associated with clinicopathological features in non-small-cell lung cancer patients. Ghasemkhani N; Shadvar S; Masoudi Y; Talaei AJ; Yahaghi E; Goudarzi PK; Shakiba E Diagn Pathol; 2015 Sep; 10():164. PubMed ID: 26377406 [TBL] [Abstract][Full Text] [Related]
11. Decreased microRNA-224 and its clinical significance in non-small cell lung cancer patients. Zhu D; Chen H; Yang X; Chen W; Wang L; Xu J; Yu L Diagn Pathol; 2014 Nov; 9():198. PubMed ID: 25410592 [TBL] [Abstract][Full Text] [Related]
12. MiR-4299 suppresses non-small cell lung cancer cell proliferation, migration and invasion through modulating PTEN/AKT/PI3K pathway. Yang WB; Zhang WP; Shi JL; Wang JW Eur Rev Med Pharmacol Sci; 2018 Jun; 22(11):3408-3414. PubMed ID: 29917192 [TBL] [Abstract][Full Text] [Related]
13. MiR-504 inhibits cell proliferation and invasion by targeting LOXL2 in non small cell lung cancer. Ye MF; Zhang JG; Guo TX; Pan XJ Biomed Pharmacother; 2018 Jan; 97():1289-1295. PubMed ID: 29156517 [TBL] [Abstract][Full Text] [Related]
14. miR-1290 is a potential prognostic biomarker in non-small cell lung cancer. Mo D; Gu B; Gong X; Wu L; Wang H; Jiang Y; Zhang B; Zhang M; Zhang Y; Xu J; Pan S J Thorac Dis; 2015 Sep; 7(9):1570-9. PubMed ID: 26543604 [TBL] [Abstract][Full Text] [Related]
15. Overexpression of miR-518b in non-small cell lung cancer serves as a biomarker and facilitates tumor cell proliferation, migration and invasion. Zhang X; Hu Y; Gong C; Zhang C Oncol Lett; 2020 Aug; 20(2):1213-1220. PubMed ID: 32724361 [TBL] [Abstract][Full Text] [Related]
16. Upregulated miR-665 expression independently predicts poor prognosis of lung cancer and facilitates tumor cell proliferation, migration and invasion. Xia J; Li D; Zhu X; Xia W; Qi Z; Li G; Xu Q Oncol Lett; 2020 May; 19(5):3578-3586. PubMed ID: 32269632 [TBL] [Abstract][Full Text] [Related]
17. MiR-638 inhibits cervical cancer metastasis through Wnt/β-catenin signaling pathway and correlates with prognosis of cervical cancer patients. Wei H; Zhang JJ; Tang QL Eur Rev Med Pharmacol Sci; 2017 Dec; 21(24):5587-5593. PubMed ID: 29271990 [TBL] [Abstract][Full Text] [Related]
18. Overexpression of miR-425-5p is associated with poor prognosis and tumor progression in non-small cell lung cancer. Fu Y; Li Y; Wang X; Li F; Lu Y Cancer Biomark; 2020; 27(2):147-156. PubMed ID: 31771046 [TBL] [Abstract][Full Text] [Related]
19. Aberrant expression of miR-4728 in patients with non-small cell lung cancer and its regulatory effects on tumor progression in tumor cells. Hu Y; Zhang X; Gong C; Li J Exp Ther Med; 2020 Nov; 20(5):15. PubMed ID: 32934680 [TBL] [Abstract][Full Text] [Related]
20. MiR-181a inhibits non-small cell lung cancer cell proliferation by targeting CDK1. Shi Q; Zhou Z; Ye N; Chen Q; Zheng X; Fang M Cancer Biomark; 2017 Dec; 20(4):539-546. PubMed ID: 28946554 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]